MedTrace Logo

Bone Metastases in neurOendocrine NEoplasms: naTural History, Prognostic Impact and Therapeutic Approach (MONET)

NCT04720391 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2021-01-22

No results posted yet for this study

Summary

This is a retrospective/prospective observational multicentric trial on patients with bone metastases from NENs.

General objectives:

* To trace on a national scale the frequency of bone metastases in patients with neuroendocrine neoplasm (NEN) and their clinical management.
* To correlate clinical and biological factors to clinical outcomes.
* To centralise and to make homogeneous clinical, pathological, instrumental and therapeutic information.
* To set up a database and to acquire biological material for studying predictive and prognostic biomarkers.

Conditions

Sponsors & Collaborators

  • European Institute of Oncology

    lead OTHER

Principal Investigators

  • Nicola Fazio, M.D., Ph.D. · European Institute of Oncology, IEO, IRCCS

  • Francesca Spada, M.D., Ph.D. · European Institute of Oncology, IEO, IRCCS

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-08
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04720391 on ClinicalTrials.gov